{
    "2018-08-21": [
        [
            {
                "time": "2018-08-22",
                "original_text": "【天风医药】行业点评：创新药专题——医保谈判开启创新药放量新周期",
                "features": {
                    "keywords": [
                        "创新药",
                        "医保谈判",
                        "放量新周期"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "恒瑞医药关于获得药物上市许可的公告",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药物上市",
                        "许可"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "恒瑞医药：盐酸右美托咪定注射液获批在日本上市",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "盐酸右美托咪定",
                        "日本上市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "浪眼财经丨石药绩后冲高领跑，歌礼、百济“决战港股”路在何方？",
                "features": {
                    "keywords": [
                        "石药",
                        "歌礼",
                        "百济",
                        "港股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "[同步大市-B评级] 医药行业周报：上海第三批带量采购落地 进一步促进行业升级",
                "features": {
                    "keywords": [
                        "带量采购",
                        "行业升级",
                        "上海"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "中证数据：两市资金净流入前20股（8月21日）",
                "features": {
                    "keywords": [
                        "资金净流入",
                        "两市"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "375亿资金争夺20股：主力资金重点出击15股(名单)",
                "features": {
                    "keywords": [
                        "资金争夺",
                        "主力资金",
                        "名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "云南白药中报低于预期 医药板块之前涨幅过高有调整需要",
                "features": {
                    "keywords": [
                        "云南白药",
                        "中报",
                        "调整"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-21",
                "original_text": "【医药*全铭】抗癌药谈判开启，利好肿瘤药创新及肿瘤伴随诊断标的",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "谈判",
                        "肿瘤药创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}